Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-191.18%Return on Assets
VS
Market
Sector
Industry
History
$ 4.81Close
$ 2.05 - $ 8.48 52-Week Range
Ticker Information
Ticker
ADVMCompany Name
ADVERUM BIOTECHNOLOGIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQADVERUM BIOTECHNOLOGIES INC - Return on Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ADVM - ROA Historical data
| Date | Total Assets | Net Income Common Stock | Return on Assets |
|---|---|---|---|
| 6/30/2025 | $ 96.18M | $ -183.87M | -191.18% |
| 3/31/2025 | $ 137.65M | $ -153.16M | -111.26% |
| 12/31/2024 | $ 179.84M | $ -130.93M | -72.8% |
| 9/30/2024 | $ 234.38M | $ -94.11M | -40.15% |
| 6/30/2024 | $ 253.8M | $ -99.86M | -39.35% |
| 3/31/2024 | $ 267.83M | $ -112.9M | -42.15% |
| 12/31/2023 | $ 173.01M | $ -117.17M | -67.72% |
| 9/30/2023 | $ 196.77M | $ -126.19M | -64.13% |
| 6/30/2023 | $ 241.43M | $ -133.43M | -55.27% |
| 3/31/2023 | $ 275.58M | $ -145.68M | -52.87% |
Key Performance Insights, Last 5 Years
- ADVERUM BIOTECHNOLOGIES INC's latest trailing twelve months (TTM) ROA stands at -19.46%.
- Over the past 5 years, ADVERUM BIOTECHNOLOGIES INC's average ROA has been -53.67%.
- The median ROA for ADVERUM BIOTECHNOLOGIES INC during this period was -41.67%
- ADVERUM BIOTECHNOLOGIES INC reached its highest ROA over the past 5 years at -19.46%.
- The lowest ROA recorded by ADVERUM BIOTECHNOLOGIES INC in the same timeframe -191.18%
ADVERUM BIOTECHNOLOGIES INC's ROA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROA Benchmarks
Similar metrics to ROA:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Equity - [Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
Definition of Return on Assets
[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.Net Inc. Cmn. / Assets
(=) ROA ROA for ADVERUM BIOTECHNOLOGIES INC is calculated as follows: Net Inc. Cmn. [ $ -98.8M ] / Assets [ $ 507.71M ]
(=) ROA [ -19.46% ] ADVM - Return on Assets, Last 5 years
-191.18%
Minimum
Jun 30, 2025
-19.46%
Maximum
Sep 30, 2020
-53.67%
Average
-41.67%
Median
ROA Benchmark AnalysisMarket
The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.12% with a standard deviation of 10.61%.
The following table provides additional summary stats:
ROA in the Market:
| filtered constituents | 3.44K |
|---|---|
| min | -33.4% |
| max | 33.98% |
| average | 0.12% |
| median | 1.53% |
| std | 10.61% |